| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 43.873 | 79.917 | 89.820 | 83.686 | 75.031 | 65.671 | - | 87.952 | 208.881 | 201.755 |
| Total Income - EUR | 44.582 | 79.917 | 89.822 | 85.043 | 75.667 | 65.671 | - | 87.952 | 208.900 | 202.617 |
| Total Expenses - EUR | 8.994 | 8.007 | 38.259 | 32.638 | 60.222 | 22.919 | - | 18.188 | 58.864 | 46.349 |
| Gross Profit/Loss - EUR | 35.588 | 71.909 | 51.563 | 52.404 | 15.445 | 42.752 | - | 69.764 | 150.036 | 156.269 |
| Net Profit/Loss - EUR | 34.250 | 69.512 | 48.868 | 49.853 | 13.175 | 40.766 | - | 67.578 | 147.947 | 134.933 |
| Employees | 2 | 2 | 2 | 0 | 0 | 0 | - | 1 | 1 | 1 |
Check the financial reports for the company - Sanpharm Production Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 987.529 | 974.368 | 956.108 | 813.571 | 779.406 | 746.570 | - | 696.851 | 677.078 | 655.732 |
| Current Assets | 57.210 | 16.118 | 3.454 | 22.111 | 9.063 | 71.173 | - | 5.622 | 6.206 | 18.706 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Receivables | 40.714 | 0 | 11 | 11 | 6.080 | 42.044 | - | 3.986 | 4.414 | 12.812 |
| Cash | 16.496 | 16.118 | 3.443 | 22.100 | 2.983 | 29.130 | - | 1.636 | 1.792 | 5.894 |
| Shareholders Funds | 23.739 | 93.171 | 140.462 | 81.519 | 33.843 | 73.967 | - | 202.833 | 350.165 | 483.141 |
| Social Capital | 157 | 156 | 153 | 150 | 148 | 145 | - | 142 | 142 | 141 |
| Debts | 1.021.000 | 897.315 | 819.100 | 754.163 | 754.626 | 743.776 | - | 499.640 | 333.118 | 191.296 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1722 - 1722" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Sanpharm Production Srl